Castration-Resistant Prostate Cancer (CRPC) Live Forum for Urology Residents & Fellows (2017)
Presented by the AUA in Partnership with The Society of Urologic Oncology (SUO)
The AUA recently released a report on the educational needs of urologists in the area of CRPC. These findings show strong support for the AUA to influence key stakeholders in urology residency programs in order to increase the amount of exposure residents receive in the area of CRPC. Additionally, the findings indicate that the AUA should look into the feasibility of developing stand-alone courses and educational materials specifically targeted to residents that covers the medical management of advanced prostate cancer.
Based on this educational need, AUA is launching a new educational initiative to focus on CRPC Resident & Fellow Training. Based on the documented need for additional education in this area, the AUA has developed multiple educational interventions to improve the urology resident and fellow's ability to care for patients with CRPC. The CRPC Resident & Fellow Training initiative is comprised of a variety of unique activities, including a self-assessment, pre-requisite work, a live forum and an online case-study activity. This activity will also provide each participant will access to patient education resources The initiative will offer the live one-day forum five times to reach residents and fellows across the country.
This initiative will provide a foundation of knowledge on CRPC and the ability to apply this knowledge into practice to improve the outcomes of their patients. As residency programs differ in what is offered, we recommend that each participant in this initiative successfully complete all of the activities. If a resident successfully completes all activities, they will receive a Certificate of Participation which they may share with their Residency Program Director.
All activities are free to urology residents and fellows.
Activity 1 – Self-Assessment
Learners are more engaged when they recognize their own knowledge gaps. An online self-assessment will both test current knowledge and provide immediate feedback. The CRPC self-assessment will be made available to all participants following their registration to the live forum on AUAUniversity. Participants will receive immediate feedback as they progress through the activity and will also receive a summary report which will identify their personal knowledge gaps.
Activity 2 – Live Forum Pre-Requisite Activities
Following the self-assessment and analysis of their results, but prior to the live forum, participants will be given access to online content to prepare them for the content which will be examined at the live forum. Free access will be provided on AUAUniversity once the participant has registered for a live forum and completed the self-assessment.
Activity 3 – CRPC Live Forum for Urology Residents & Fellows
As the capstone to this initiative, a live, interactive forum will be held for participants to engage with subject matter expects and mentors. For convenience, participants can choose from one of five dates and locations. Locations have been strategically selected based on the distribution of residents.
At the conclusion of this activity, participants will be able to:
- Describe the natural course of prostate cancer from early to late stages, including the acquisition of castration resistant disease.
- Explain the implications of castrate resistance on the management of prostate cancer.
- Discuss specific recommendations within the AUA Clinical Practice Guidelines.
- Construct a patient care plan using the AUA Clinical Practice Guidelines.
- Identify recently approved therapeutics for CRPC.
- Contrast the mechanisms of action of recently approved therapeutics for CRPC.
- Appraise the clinical efficacy of recently approved therapeutics for CRPC.
- Organize and order approved therapeutics for use in patients with CRPC.
- Appraise immunosuppressive agents and other medications used in the treatment of CRPC for potential interactions.
- Integrate advances in bone health management into patient-specific care plans.
- Proactively manage side effects of medications used for the treatment of CRPC.
- Identify, assess, and manage comorbid conditions often found in patients with CRPC.
- Assess and manage pain in patients with CRPC.
- Counsel patients on medication adherence.
- Support patients at the end of the patients' life.
Activity 4 – AUA Clinical Problem Solving (CPS) Protocol Online Activity
The AUA Clinical Problem Solving (CPS) Protocol is a very successful online series that is hosted on AUAUniversity. The AUA is developing a new and specific CPS Protocol on CRPC specifically for residents and fellows to support and enhance the learning from the live forum. This activity will allow the participant to apply the information they have learned on CRPC and focus on the practice-based application of the CRPC Guidelines.
At the completion of this CPS activity, the learner will be able to:
- Interpret and explain the appropriate diagnosis, prevention and treatment of the related guideline.
- Perform appropriate methods of evaluation and management according to the guideline.
- Analyze the risks and benefits for treatment according to the guideline.
- Integrate this AUA guideline into clinical practice.
Activity 5 – CRPC Patient Education Resources
To encourage and support the participant's care of their patients, this activity will provide links to Urology Care Foundation existing resources on CRPC. These resources will include patient videos and brochures.
Certificate of Participation
Education is specific to each unique learner, but this initiative has been developed to provide an encompassing review of CRPC for residents and fellows. To encourage each participant to take full advantage of this breadth of materials, AUA will generate a Certificate of Participation if the participant successfully completes a specific amount of the activities. The residents can share this certificate with their residency programs as proof of completion.
- Urology Fellows
Michael Cookson, MD, MMHC
David Jarrard, MD
|Michael S. Cookson, MD||TesoRx Pharma LLC||Consultant or Advisor||Yes||02/24/2017|
|Michael S. Cookson, MD||Janssen Biotech, Inc.||Consultant or Advisor||Yes||02/24/2017|
|Michael S. Cookson, MD||Myovant Sciences||Consultant or Advisor||Yes||01/18/2018|
|Michael S. Cookson, MD||MDxHealth||Consultant or Advisor||Yes||06/01/2017|
|Michael S. Cookson, MD||Bayer Healthcare Pharmaceuticals||Consultant or Advisor||Yes||01/18/2018|
|David F. Jarrard, MD||Gregor Diagnostics||Consultant or Advisor||No||12/18/2016|
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association designates this live activity and enduring material for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education
- Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
- 9.00 AMA PRA Category 1 Credit™
- 9.00 Non-Physician Participation